跳至主要内容
临床试验/NCT05228847
NCT05228847尚未招募不适用

Effect of Human Milk-derived Fortifiers on Weight Gain in Preterm Infants <1250 g: A Randomized Controlled Trial

University of Calgary1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2023年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
42
试验地点
1
主要终点
Average weight gain

研究概览

简要总结

Human Milk alone is unable to meet the high nutritional requirements of preterm infants. The American Academy of Pediatrics recommends fortification of human milk as a standard practice in all very low birth weight (VLBW) infants. Multi-nutrient human milk fortifiers (HMFs) are designed to meet the macro and micro-nutrient needs of VLBW infants. HMFs differ by the origin of milk and by nutrient composition. Traditionally, bovine milk has been the main source of multi-nutrient HMFs.

详细描述

Recent advances in lacto-engineering techniques allowed the manufacturing of multi-nutrient HMF from human milk as an alternative to bovine milk. Since exposure to infant bovine-based formula feeds is frequently shown to increase neonatal morbidities, human milk-derived HMFs (H-HMFs) have been frequently proposed to minimize exposure to bovine products prior to 34 weeks gestation with an intent to decrease the risks of necrotizing enterocolitis and feeding intolerance. The use of multi-nutrient H-HMFs is a promising intervention however currently available H-HMFs are expensive.

The main objective of this randomized controlled trial is to compare the weight gain achieved by preterm infants born <1250 g and fed human milk fortified with H-HMFs (made from mother's own milk (MOM) when MOM supply exceeds the daily need of her preterm infant or from donor human milk (DHM) compared with counterparts fed human milk fortified with the currently used bovine-derived fortifier (B-HMF).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
3 Days 至 12 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Birthweight between 400 g-1250 g
  • •Less than or 32 weeks gestational age at birth
  • •Subject has been classified as appropriate for gestational age
  • •Enteral feeding of human milk is initiated by 72 hours
  • •Subject is expected to be on human milk for at least 3 weeks.

排除标准

  • •Congenital abnormalities or underlying disease that may affect growth
  • •Maternal cocaine, alcohol, or opioid abuse during pregnancy
  • •Mother or infant is currently receiving treatment for HIV infection
  • •Infant with major surgery

研究组 & 干预措施

Human milk-derived HMF

Active Comparator

Fortification with human milk-derived product

干预措施: Human milk-derived HMF (Dietary Supplement)

Bovine milk-derived HMF

Other

Current standard practice: Fortification with bovine milk-derived product

干预措施: bovine milk-derived HMF (Dietary Supplement)

结局指标

主要结局

Average weight gain

时间窗: up to 3 weeks

Average weight gain measured as g/kg per day

次要结局

  • Head circumference(Weekly for 8 weeks)
  • Length(Weekly for 8 weeks)
  • Feed intolerance(3 weeks)
  • Electrolytes abnormalities(3 weeks)
  • Need for additional signal nutrient supplementation(3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Belal Alshaikh

Clinical Associate Professor, Department of Pediatrics

University of Calgary

研究点 (1)

Loading locations...

相似试验